ArticleResearch square2026
Profiling of Both Dipeptidyl Peptidase III and Renin Reveals Higher Mortality in Septic Shock.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Sepsis and septic shock are life-threatening conditions associated with high mortality and limited treatment options. Rapid identification of patients at risk for worse outcomes and/or targeted therapeutics are needed. Elevated levels of renin and dipeptidyl peptidase III (DPP3) individually have been associated with increased risk in septic shock, which may reflect an attenuated Angiotensin II response as DPP3 contributes to the metabolism of Angiotensin II. We applied an approach to distinguish both circulating renin and DPP3 concentrations at their clinically relevant threshold values for risk in septic shock patients of ≥ 180 pg/mL and ≥ 40 ng/mL, respectively. This analysis revealed four clinical phenotypes of patients with low risk (low renin/low DPP3), intermediate risk (high renin/low DPP3 or low renin/high DPP3) and those patients with the highest risk (high renin/high DPP3). We conclude that the subclassification of both circulating renin and DPP3 concentrations may better identify those patients at greater risk and inform more optimal treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.